Results 101 to 110 of about 30,729 (226)

Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial

open access: yesDigital Health
Background Although smartphone application for smoking cessation was considered a promising strategy, there were scarce studies on the combination of usual interventions and apps for smoking cessation in China. Our study aimed to evaluate the efficacy of
Xiao-Wen Wei   +11 more
doaj   +1 more source

Sigara bırakma tedavisi sırasında Bupropion Hcl’e bağlı gelişen serum hastalığı benzeri reaksiyon: Olgu sunumu

open access: yesTurkish Journal of Family Practice, 2017
Dünyada önlenebilir erken ölüm ve sakatlık nedenlerinin başında sigara kullanımı yer almaktadır. Nikotin replasman tedavisi (NRT), vareniklin ve bupropion HCL başlıca sigara bırakma ilaçlarıdır.
Ruhuşen Kutlu   +2 more
doaj   +1 more source

Society for Maternal‐Fetal Medicine Special Statement: Guidance to reduce racial disparities in substance use screening and biological testing in pregnancy at the delivery admission

open access: yesPregnancy, Volume 2, Issue 6, November 2026.
Abstract Substance use complicates upward of 10% of US pregnancies. The Society for Maternal‐Fetal Medicine, the American College of Obstetricians and Gynecologists, and the American Society of Addiction Medicine have jointly recommended universal screening for substance use during pregnancy using a validated tool, without recommending universal ...
Society for Maternal‐Fetal Medicine (SMFM)   +8 more
wiley   +1 more source

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

open access: yesAddiction, Volume 121, Issue 11, Page 2897-2958, November 2026.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson   +13 more
wiley   +1 more source

SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile

open access: yesFrontiers in Pharmacology
BackgroundEsketamine, the first Food and Drug Administration-approved fast-acting antidepressant, has limited use because of its addictive properties.
Ying Xiao   +9 more
doaj   +1 more source

Dextromethorphan Hydrobromide‐Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand‐Alone Drugs

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Eric E. Brown   +2 more
wiley   +1 more source

Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6‐Month Claims Database Analysis

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9966-9979, November 2026.
ABSTRACT Aims Tirzepatide is a once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) approved in the US for the treatment of Type 2 diabetes (T2D), weight loss and obstructive sleep apnoea. This study aimed to assess the utilisation and effectiveness of tirzepatide among individuals in a large ...
Theresa Hunter Gibble   +7 more
wiley   +1 more source

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice

open access: yesNeurology Research International, 2018
Hesperidin, a well-known flavanone glycoside mostly found in citrus fruits, showed neuroprotective and antidepressant activity. Agomelatine, a melatonergic MT1/MT2 agonist and 5-HT2C receptor antagonist, exhibits good antidepressant efficacy.
Jegan Sakthivel Nadar   +4 more
doaj   +1 more source

The Effect of Behavioral Sleep Interventions on Measures of Obesity, Dietary Intake and Physical Activity in Adults With Poor Sleep Health: A Systematic Review, Meta‐Analysis and Meta‐Regression Analysis

open access: yesObesity Reviews, Volume 27, Issue 11, November 2026.
ABSTRACT Background As poor sleep negatively impacts on adiposity, there is interest in examining whether improving sleep can improve adiposity markers. We reviewed studies aimed at improving sleep using (1) cognitive behavioral therapy for insomnia (CBT‐I) and/or sleep hygiene and (2) sleep extension on adiposity markers, dietary intake, and physical ...
Samiul A. Mostafa   +7 more
wiley   +1 more source

The use of bupropion SR in cigarette smoking cessation

open access: yesInternational Journal of COPD, 2008
Scott WilkesDepartment of Primary and Community Care, School of Health, Natural and Social Sciences, University of Sunderland, Sunderland, United KingdomAbstract: Cigarette smoking remains the largest preventable cause of premature death in developed ...
Scott Wilkes
doaj  

Home - About - Disclaimer - Privacy